|
HSP's Capital Expenditures Growth by Quarter and Year
Hospira,'s Capital Expenditures results by quarter and year
|
Select the Comparisons :
|
|
Select the Ratio:
|
Capital Expenditures Growth Y/Y▼
|
Capital Expenditures Growth Y/Y▼
|
| HSP Capital Expenditures (in millions $) |
FY 2014 |
FY 2013 |
FY 2012 |
FY 2011 |
| IV Quarter |
December |
-
|
-249.90
|
88.30
|
79.20
|
| III Quarter |
September |
94.20
|
95.80
|
64.40
|
72.70
|
| II Quarter |
June |
89.70
|
84.10
|
70.10
|
76.40
|
| I Quarter |
March |
95.10
|
68.60
|
67.30
|
62.20
|
| FY |
|
279.00
|
-1.40
|
290.10
|
290.50
|
| HSP Capital Expenditures third quarter 2014 Y/Y Growth Comment |
Hospira, Inc. reported decrease in Capital Expenditures in the third quarter 2014 by -1.67% to $ 94.20 millions, from the same quarter in 2013.
The decrease in the third quarter 2014 Hospira, Inc.'s Capital Expenditures compares unfavorably to the Company's average Capital Expenditures growth of 1.34%.
Looking into third quarter 2014 results within Major Pharmaceutical Preparations industry 78 other companies have achieved higher Capital Expenditures growth. While Hospira, Inc.' s Capital Expenditures decline of -1.67% ranks overall at the positon no. 1749 in the third quarter 2014.
|
| HSP Capital Expenditures ( Y/Y Growth %) |
2014
|
2013 |
2012 |
2011 |
| IV Quarter |
December |
- |
- |
11.49 % |
-62.01 % |
| III Quarter |
September |
-1.67 % |
48.76 % |
-11.42 % |
-48.73 % |
| II Quarter |
June |
6.66 % |
19.97 % |
-8.25 % |
-3.78 % |
| I Quarter |
March |
38.63 % |
1.93 % |
8.2 % |
53.2 % |
| FY |
|
- |
- |
-0.14 % |
-38.23 % |
HSP Capital Expenditures (Quarter on Quarter Growth %) |
2014
|
2013 |
2012 |
2011 |
| IV Quarter |
December |
- |
- |
37.11 % |
8.94 % |
| III Quarter |
September |
5.02 % |
13.91 % |
-8.13 % |
-4.84 % |
| II Quarter |
June |
-5.68 % |
22.59 % |
4.16 % |
22.83 % |
| I Quarter |
March |
- |
-22.31 % |
-15.03 % |
-70.17 % |
| FY (Year on Year) |
|
- |
- |
-0.14 % |
-38.23 % |
| Capital Expenditures Y/Y Growth Statistics |
| High |
Average |
Low |
| 53.2 % |
1.34 % |
-100 % |
| (March 31, 2011) |
|
(Dec 31 2011) |
|
|
| Capital Expenditures Y/Y Growth Statistics |
| High |
Average |
Low |
| 53.2 % |
1.34 % |
-100 % |
| (March 31, 2011) |
|
(Dec 31 2011) |
|
| Capital Expenditures by Quarter for the Fiscal Years 2011, 2012, 2013, 2014 |
Hospira,'s Q/Q Capital Expenditures Growth
| Capital Expenditures Q/Q Growth Statistics |
| High |
Average |
Low |
| 130.18 % |
12.01 % |
-100 % |
| (June 30, 2009) |
|
(Dec 31 2011) |
| HSP's III. Quarter Q/Q Capital Expenditures Comment |
HOSPIRA, INC. achieved in the III. Quarter 2014 below company average Capital Expenditures increase of 5.02% quarter on quarter, to $ 94.20 millions.
Within Major Pharmaceutical Preparations industry 85 other companies have achieved higher Capital Expenditures quarter on quarter growth. While Hospira,'s Capital Expenditures growth quarter on quarter, overall rank is 1893. |
|
|
|
| Capital Expenditures Q/Q Growth Statistics |
| High |
Average |
Low |
| 130.18 % |
12.01 % |
-100 % |
| (June 30, 2009) |
|
(Dec 31 2011) |
| HSP's III. Quarter Q/Q Capital Expenditures Comment |
HOSPIRA, INC. achieved in the III. Quarter 2014 below company average Capital Expenditures increase of 5.02% quarter on quarter, to $ 94.20 millions.
Within Major Pharmaceutical Preparations industry 85 other companies have achieved higher Capital Expenditures quarter on quarter growth. While Hospira,'s Capital Expenditures growth quarter on quarter, overall rank is 1893. |
|
Hospira,'s 12 Months Capital Expenditures Growth Year on Year
Capital Expenditures TTM Growth |
12 Months Ending
(Sep. 30, 2014) |
12 Months Ending
(June 30. 2014) |
12 Months Ending
(March 31, 2014) |
12 Months Ending
(Dec 31 2013) |
12 Months Ending
(Sep. 30, 2013) |
| Cumulative Capital Expenditures 12 Months Ending |
$ 384.00 |
$ 385.60 |
$ 380.00 |
$ -1.40 |
$ 336.80 |
| Y / Y Capital Expenditures Growth (TTM) |
14.01 % |
26.26 % |
30.4 % |
- |
- |
| Year on Year Capital Expenditures Growth Overall
Ranking |
# 1114 |
# 1238 |
# 1238 |
# 1238 |
# 1144 |
| Seqeuential Capital Expenditures Change (TTM) |
-0.41 % |
1.47 % |
7.5 % |
- |
10.28 % |
| Seq. Capital Expenditures Growth (TTM) Overall
Ranking |
# 1476 |
# 1784 |
# 0 |
# 0 |
# 1513 |
| Cumulative Capital Expenditures growth
Comment |
With the quarterly Capital Expenditures reported in the Sep. 30, 2014 period, Hospira,'s cumulative twelve months Capital Expenditures were $ 384 millions, company would post below average annual Capital Expenditures growth of 10.28% year on year, if the fiscal year would end at Sep. 30, 2014.
A slow-down in the Hospira,'s Capital Expenditures growth from the 89.7% growth in June 30. 2014.
In the Healthcare sector 108 other companies have achieved higher trailing twelve month Capital Expenditures growth. While Total ranking has impoved so far to 1114, from total ranking in previous quarter at 1238. |
| Capital Expenditures TTM Q/Q Growth Statistics |
| High |
Average |
Low |
490.45 % |
25.96 % |
-30.8 % |
|
|
|
|
|
| Capital Expenditures TTM Y/Y Growth Statistics |
| High |
Average |
Low |
538.18 % |
35.2 % |
-40.83 % |
|
|
|
| Capital Expenditures TTM Q/Q Growth Company Ranking |
| Within: |
No. |
| Industry |
# 43 |
| Sector |
# 152 |
| S&P 500 |
# 1476 |
|
| Cumulative Capital Expenditures growth
Comment |
With the quarterly Capital Expenditures reported in the Sep. 30, 2014 period, Hospira,'s cumulative twelve months Capital Expenditures were $ 384 millions, company would post below average annual Capital Expenditures growth of -40.83% year on year, if the fiscal year would end at Sep. 30, 2014.
A slow-down in the Hospira,'s Capital Expenditures growth from the 89.7% growth in June 30. 2014.
In the Healthcare sector 108 other companies have achieved higher trailing twelve month Capital Expenditures growth. While Total ranking has impoved so far to 1114, from total ranking in previous quarter at 1238. |
| Capital Expenditures TTM Q/Q Growth Statistics |
| High |
Average |
Low |
490.45 % |
25.96 % |
-30.8 % |
|
|
|
| Capital Expenditures TTM Y/Y Growth Statistics |
| High |
Average |
Low |
538.18 % |
35.2 % |
-40.83 % |
|
|
|
| Capital Expenditures TTM Q/Q Growth Company Ranking |
| Within: |
No. |
| Industry |
# 43 |
| Sector |
# 152 |
| S&P 500 |
# 1476 |
|
